BIND

BIND Therapeutics to Present at 26th Annual Roth Conference

[Business Wire] – BIND Therapeutics, Inc. , a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the 26 moreView todays social media effects on BINDView the latest stocks trending across Twitter. Click to view dashboardSee who BIND is hiring next, click here to […]

BIND Therapeutics to Present at Cowen 34th Annual Healthcare Conference

[Business Wire] – BIND Therapeutics, Inc. , a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Co moreView todays social media effects on BINDView the latest stocks trending across Twitter. Click to view dashboardSee who BIND is hiring next, click here to […]

BIND Therapeutics Is Worth $18/Share

moreView todays social media effects on BINDView the latest stocks trending across Twitter. Click to view dashboardSee who BIND is hiring next, click here to view […]

3 Biotech Stocks Rising on Big Volume

moreView todays social media effects on BINDView the latest stocks trending across Twitter. Click to view dashboardSee who BIND is hiring next, click here to view […]